House E&C Leaders Announce Leadership Team and New Committee Members

U.S. House Energy & Commerce party leaders recently announced new committee members.

U.S. House Energy and Commerce (E&C) Chair Frank Pallone (D-N.J.) last Friday formally announced Rep. Anna Eshoo (D-Calif.) as Health subcommittee chair and Rep. Diana DeGette (D-Colo.) as leader of the Oversight and Investigations subcommittee.

Eshoo, who is based

Read More »

Our First Issue Behind Our Paywall

340B Report’s content including full articles is now available exclusively for paid subscribers. For those who have already paid, we sincerely thank you. If you have any questions about logging in, please contact Reshma Eggleston at reshma.eggleston@340Breport.com

For those who have not

Read More »

Gilead Adjusts Planned Change in its Patient Assistance After HIV Community Pushes Back

NASTAD and others in the HIV community said they raised their concerns with Gilead about its planned change to its patient assistance program, and the company appears to have listened. | Source: Shutterstock

Drug manufacturer Gilead has altered a planned change to its patient assistance program (PAP) for uninsured people living with HIV that would have been unworkable for some vulnerable patients, HIV/AIDS caregivers and activists say. The change also would have deprived

Read More »

HHS Asks Court to Toss Out Hospitals’ 340B Contract Pharmacy Lawsuit

The lawsuit against HHS by 340B hospitals is just one of several underway over drug manufacturers’ denials of 340B pricing on drugs dispensed by contract pharmacies. | Source: Shutterstock

Outgoing U.S. Health and Human Services (HHS) Secretary Alex Azar last week asked a federal district judge to dismiss a lawsuit against him and his department by 340B hospitals over HHS’s enforcement of its 340B contract pharmacy requirements for drug

Read More »

Senate Finance Report Might Shed Light on Insulin Manufacturers’ 340B Contract Pharmacy Actions

HHS has for the second time delayed the effective date of a Trump administration rule to require health centers to provide insulin and injectable epinephrine to low-income patients at the price the centers pay for those drugs under the 340B program. The new date is July 20. | Shutterstock

U.S. insulin manufacturer and pharmacy benefit manager (PBM) business practices “have created a vicious cycle of price increases that have sent costs for patients and taxpayers through the roof,” U.S. Senate Finance Committee leaders Chuck Grassley (R-Iowa) and Ron Wyden

Read More »

Azar and Verma Touch on 340B in Valedictory Remarks

Outgoing HHS Secretary Alex Azar (left) and CMS Administrator Seema Verma touched on 340B in farewell remarks.| Source: C-SPAN

Outgoing U.S. Health and Human Services (HHS) Secretary Alex Azar and Centers for Medicare & Medicaid Services (CMS) Administrator Seema Verma both referred to 340B—obliquely in Azar’s case, directly in Verma’s—in recent farewell remarks.

In an interview with Modern Healthcare

Read More »

340B Stakeholders Reconsider Campaign Contributions in Wake of Capitol Riot

Businesses and groups involved in 340B are reconsidering their political donations following a pro-Trump mob's assault on the U.S. Capitol. | Source: Shutterstock

National health care organizations and businesses with major stakes in the 340B program have suspended political contributions following a pro-Trump mob’s Jan. 6 violent attack on Congress to stop it from counting and certifying the Electoral College’s votes for president.

Read More »
Industry Insights Logo

Top 10 Issues to Consider in 2021 – Sponsored Content

SPONSORED CONTENT by Jim Jorgenson, CEO, Visante

2020 was a year like no other! Dominated by challenges and uncertainty with the pandemic and the economy, and the political landscape overshadowing everything.

As always, and particularly in the face of rising challenges, we would like to thank our many clients for trusting us to support their organizations and to help them weather the storm as we head into what will

Read More »

Important Information About Accessing 340B Report

We hope you are enjoying 340B Report’s new website and email platform that we launched yesterday. If you or a colleague did not receive the issue in your in-box, please make sure to mark us as a safe sender and add 

Read More »

Health Centers File 340B Dispute Resolution Petitions Against Drug Manufacturers

The National Association of Community Health Centers (NACHC) last night on its members’ behalf asked a new federal 340B program administrative dispute resolution (ADR) panel to order drug manufacturers Eli Lilly and Co., Sanofi, and AstraZeneca to lift all “qualifications,

Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live